{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:07:20Z","timestamp":1748664440884,"version":"3.41.0"},"reference-count":36,"publisher":"Termedia Sp. z.o.o.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatologia"],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Axial spondyloarthritis (axSpA) comprises a group of chronic inflammatory joint diseases. Modern therapies enable the rapid achievement of low disease activity or even remission. Therefore, assessing disease activity is now crucial for making the best possible therapeutic decisions. In addition to standard clinical indices used to evaluate disease activity, magnetic resonance imaging (MRI) is increasingly employed to assess inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>The study included patients with axSpA who had a Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score \u2265 4 and a Spondyloarthritis Research Consortium of Canada (SPARCC) score \u2265 2. The MRI examinations of the sacroiliac joints were performed at the beginning and the end of the study to evaluate disease activity. The study lasted 3 months, during which patients were treated with certolizumab pegol.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included 31 patients with axSpA (11 females, 20 males). The mean age of the patients was 36.7 years (SD 9.7), and the mean disease duration from the onset of the first symptoms was 7.4 years (SD 1.9). At the start of therapy, all patients had active disease, as determined by clinical assessment (BASDAI \u2265 4 and Ankylosing Spondylitis Disease Activity Score [ASDAS] &gt; 2.1) and MRI eva\u00adluation (SPARCC \u2265 2). The percentage of patients with active disease after 3 months of therapy was 26% (BASDAI), 19% (ASDAS), and 97% (SPARCC). Significant clinical improvement as a result of the the\u00adrapy was observed in 81% (DBASDAI \u2265 50%), 97% (DASDAS \u2265 1.1), and 87% (DSPARCC \u2265 2.5) of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Magnetic resonance imaging provides a perspective on disease activity that complements traditionally used clinical indices. It does not replace these indices but rather offers additional insights during both the diagnostic process and the monitoring of therapy efficacy.<\/jats:p><\/jats:sec>","DOI":"10.5114\/reum\/200528","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T11:08:12Z","timestamp":1748603292000},"source":"Crossref","is-referenced-by-count":0,"title":["The role of magnetic resonance imaging in monitoring patients with axial spondyloarthritis"],"prefix":"10.5114","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1132-3993","authenticated-orcid":true,"given":"Rafa\u0142","family":"Wojciechowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"ref-1448074","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken506"},{"key":"ref-1448075","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.02.007"},{"key":"ref-1448076","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-002-0261-4"},{"key":"ref-1448077","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0977-2"},{"key":"ref-1448078","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-022-05109-0"},{"key":"ref-1448079","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20970028"},{"key":"ref-1448080","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55459"},{"key":"ref-1448081","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X11436240"},{"key":"ref-1448082","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101874"},{"key":"ref-1448083","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-06018-6"},{"key":"ref-1448084","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00296"},{"key":"ref-1448085","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-022-04018-4"},{"key":"ref-1448086","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108217"},{"key":"ref-1448087","doi-asserted-by":"crossref","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68:777\u2013783, DOI: 10.1136\/ard.2009.108233.","DOI":"10.1136\/ard.2009.108233"},{"key":"ref-1448089","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.110767"},{"key":"ref-1448090","unstructured":"Landew\u00e9 RB, Hermann KG, van der Heijde DM, et al. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment. J Rheumatol 2005; 32: 2050\u20132055."},{"key":"ref-1448091","doi-asserted-by":"publisher","DOI":"10.1002\/art.39001"},{"key":"ref-1448092","doi-asserted-by":"publisher","DOI":"10.1002\/art.21445"},{"key":"ref-1448093","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-015-0522-3"},{"key":"ref-1448094","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138594"},{"key":"ref-1448095","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2936-8"},{"key":"ref-1448096","doi-asserted-by":"publisher","DOI":"10.46497\/ArchRheumatol.2024.10401"},{"key":"ref-1448097","doi-asserted-by":"publisher","DOI":"10.5114\/reum\/185429"},{"key":"ref-1448098","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1644-6"},{"key":"ref-1448099","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218808"},{"key":"ref-1448100","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204231"},{"key":"ref-1448101","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02650-4"},{"key":"ref-1448102","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3143069"},{"key":"ref-1448103","doi-asserted-by":"publisher","DOI":"10.3390\/life12040470"},{"key":"ref-1448104","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2021.21022"},{"key":"ref-1448105","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03127-2"},{"key":"ref-1448106","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkae139"},{"key":"ref-1448107","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220136"},{"key":"ref-1448108","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab755"},{"key":"ref-1448109","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2023-0495"},{"key":"ref-1448110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105352"}],"container-title":["Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/reu.termedia.pl\/pdf-200528-125661","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reu.termedia.pl\/pdf-200528-125661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T11:08:15Z","timestamp":1748603295000},"score":1,"resource":{"primary":{"URL":"https:\/\/reu.termedia.pl\/The-role-of-magnetic-resonance-imaging-in-monitoring-patients-with-axial-spondyloarthritis,200528,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":36,"alternative-id":["200528"],"URL":"https:\/\/doi.org\/10.5114\/reum\/200528","relation":{},"ISSN":["0034-6233","2084-9834"],"issn-type":[{"value":"0034-6233","type":"print"},{"value":"2084-9834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}